Literature DB >> 27626523

Twenty Years of Global Surveillance of Antituberculosis-Drug Resistance.

Matteo Zignol1, Anna S Dean1, Dennis Falzon1, Wayne van Gemert1, Abigail Wright1, Armand van Deun1, Françoise Portaels1, Adalbert Laszlo1, Marcos A Espinal1, Ariel Pablos-Méndez1, Amy Bloom1, Mohamed A Aziz1, Karin Weyer1, Ernesto Jaramillo1, Paul Nunn1, Katherine Floyd1, Mario C Raviglione1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27626523     DOI： 10.1056/NEJMsr1512438

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  35 in total

1.  Time to Multidrug-Resistant Tuberculosis Treatment Initiation in Association with Treatment Outcomes in Shanghai, China.

Authors:  Yong Chen; Zhengan Yuan; Xin Shen; Jie Wu; Zheyuan Wu; Biao Xu
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

2.  Implementation of multidrug-resistant tuberculosis (MDR-TB) treatment in Gabon: lessons learnt from the field.

Authors:  U Ateba-Ngoa; J R Edoa; B R Adegbite; E G Rossatanga; D Madiou; A Mfoumbi; C Mevyann; P Achimi Agbo; J Mahoumbou; S Gould; B Lell; A A Adegnika; C Köhler; P G Kremsner; M Massinga-Loembe; A Alabi; M P Grobusch
Journal:  Infection       Date:  2019-05-09       Impact factor: 3.553

3.  Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.

Authors:  Payam Nahid; Sundari R Mase; Giovanni Battista Migliori; Giovanni Sotgiu; Graham H Bothamley; Jan L Brozek; Adithya Cattamanchi; J Peter Cegielski; Lisa Chen; Charles L Daley; Tracy L Dalton; Raquel Duarte; Federica Fregonese; C Robert Horsburgh; Faiz Ahmad Khan; Fayez Kheir; Zhiyi Lan; Alfred Lardizabal; Michael Lauzardo; Joan M Mangan; Suzanne M Marks; Lindsay McKenna; Dick Menzies; Carole D Mitnick; Diana M Nilsen; Farah Parvez; Charles A Peloquin; Ann Raftery; H Simon Schaaf; Neha S Shah; Jeffrey R Starke; John W Wilson; Jonathan M Wortham; Terence Chorba; Barbara Seaworth
Journal:  Am J Respir Crit Care Med       Date:  2019-11-15       Impact factor: 21.405

4.  Resistance to First-Line Antituberculosis Drugs in Washington State by Region of Birth and Implications for Latent Tuberculosis Treatment Among Foreign-Born Individuals.

Authors:  Nathan W Furukawa; Mahri Z Haider; Sheanne J Allen; Sherry L Carlson; Scott W Lindquist
Journal:  Am J Trop Med Hyg       Date:  2017-04-06       Impact factor: 2.345

Review 5.  Towards Solving Health Inequities: A Method to Identify Ideological Operation in Global Health Programs.

Authors:  Hani Kim; Uros Novakovic
Journal:  Int J Environ Res Public Health       Date:  2021-04-21       Impact factor: 3.390

6.  The variability and reproducibility of whole genome sequencing technology for detecting resistance to anti-tuberculous drugs.

Authors:  Jody Phelan; Denise M O'Sullivan; Diana Machado; Jorge Ramos; Alexandra S Whale; Justin O'Grady; Keertan Dheda; Susana Campino; Ruth McNerney; Miguel Viveiros; Jim F Huggett; Taane G Clark
Journal:  Genome Med       Date:  2016-12-22       Impact factor: 11.117

7.  World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update.

Authors:  Dennis Falzon; Holger J Schünemann; Elizabeth Harausz; Licé González-Angulo; Christian Lienhardt; Ernesto Jaramillo; Karin Weyer
Journal:  Eur Respir J       Date:  2017-03-22       Impact factor: 16.671

Review 8.  Potential Application of Combined Therapy with Lectins as a Therapeutic Strategy for the Treatment of Bacterial Infections.

Authors:  João Victor de Oliveira Santos; Ana Lúcia Figueiredo Porto; Isabella Macário Ferro Cavalcanti
Journal:  Antibiotics (Basel)       Date:  2021-05-02

Review 9.  World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update.

Authors:  Fuad Mirzayev; Kerri Viney; Nguyen Nhat Linh; Licé Gonzalez-Angulo; Medea Gegia; Ernesto Jaramillo; Matteo Zignol; Tereza Kasaeva
Journal:  Eur Respir J       Date:  2021-06-04       Impact factor: 33.795

10.  Culture and Next-generation sequencing-based drug susceptibility testing unveil high levels of drug-resistant-TB in Djibouti: results from the first national survey.

Authors:  Elisa Tagliani; Mohamed Osman Hassan; Yacine Waberi; Maria Rosaria De Filippo; Dennis Falzon; Anna Dean; Matteo Zignol; Philip Supply; Mohamed Ali Abdoulkader; Hawa Hassangue; Daniela Maria Cirillo
Journal:  Sci Rep       Date:  2017-12-15       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.